USPTO serial 79364601
AXPLORA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 3, 2025
- Examiner
- UKAOMA, ULOMA JANET
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with AXPLORA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
B. Michelle Alvey
B. Michelle Alvey Husch Blackwell LLP8001 Forsyth Boulevard, Suite 1500St. Louis, MO 63105United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products in the nature of chemicals for use in industry and science, specifically for the pharmaceutical, cosmetics, agrochemistry, food, and polymers industries; biochemical catalysts, catalysts for chemical and biochemical processes, catalysts for use in the manufacture of industrial chemicals; chemical additives, chemical additives for use in the manufacture of food, chemical additives for use in the manufacture of pharmaceuticals, chemical additives for use in the manufacture of cosmetics, chemical additives for gasoline; biochemical reagents used for non-medical purposes, chemical reagents, other than for medical or veterinary purposes, reagents for scientific and research use, research reagents for industrial use, namely, for food testing, chemical diagnostic reagents for industrial use; intermediate products of synthesis, namely, chemicals used in industry, namely, intermediate products for the cosmetic, pharmaceutical, agrochemistry, food, and polymers industries; active principles, namely, active chemical ingredients for use in the manufacture of pharmaceuticals, agrochemicals, and explosives; fertilizers; all of the foregoing for use in the pharmaceutical, cosmetics, agrochemistry, food, and polymers industries; intermediary products for the synthesis of pharmaceutical, veterinary, sanitary and cosmetic active principles, namely, chemical products being synthesized pharmaceutical intermediates for the production of active pharmaceutical ingredients used in the manufacture of pharmaceuticals | ACTIVE | — |
| 003 | Purified essential oil extracts for use in the pharmaceutical, cosmetics, agrochemistry, food, and polymers industries | ACTIVE | — |
| 005 | Pharmaceutical, veterinary, sanitary products, namely, steroids, diuretic preparations, anti-inflammatory preparations, dietary supplements, nutritional supplements, diagnostic agents for medical purposes being visualization agents for use during colonoscopies, contraceptive preparations, preparations for the treatment of burns, pharmaceutical preparations for the treatment of primary biliary cirrhosis in the nature of a cholelitholytic agent, pharmaceutical preparations and substances for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, oncological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; fungicides, herbicides, insecticides, and pesticides | ACTIVE | — |
| 040 | Custom manufacturing of pharmaceutical and chemicals and their components; contract and toll custom manufacturing in the fields of pharmaceuticals, chemicals and biotechnology; preparation and transformation being custom manufacture of vaccine adjuvants, vaccines, proteins, semi-synthetic molecules, conjugated molecules, nucleic acids, polysaccharides and other therapeutic biomolecules; preparation and transformation being custom manufacture on a pilot and commercial scale of vaccine adjuvants, vaccines, proteins, semi-synthetic molecules, conjugated molecules, nucleic acids, polysaccharides, and other therapeutic biomolecules; preparation being processing of functional food and food ingredients; pilot and commercial scale preparation being processing of functional food and food ingredients; preparation and transformation being custom manufacture of chemical products, active pharmaceutical ingredients and synthetic intermediates, and agrochemical active ingredients and synthetic intermediates; preparation and transformation being custom manufacture on a pilot and commercial scale of chemical products, active pharmaceutical ingredients and synthetic intermediates, and agrochemical active ingredients and synthetic intermediates | ACTIVE | — |
| 042 | Providing quality control, namely, analytic control and authentication services for others; conducting of technical feasibility studies; technical and scientific research and development on new and existing products, notably for the food, chemical, agriculture, veterinary, pharmaceutical industries; scientific research and development in the field of performance of chemical synthesis for others; biological research, namely, synthesis of biological products for clients operating in the food, chemical, agriculture, veterinary, pharmaceutical fields; scientific research and development in the field of synthesis of intermediate products, notably of intermediate organic products for industrial purposes, notably for the food, chemical, agriculture, veterinary, pharmaceutical industries; scientific research and development in the field of synthesis of hazardous products, synthesis of substitution aromates and chiral molecules, notably synthesis of products for others; scientific research in the field of into galenic forms, specifically for others; preparation of galenic formulations, specifically for others | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Axplora Group GmbH
- Other trademarks owned by Axplora Group GmbH
- Other trademarks owned by Axplora Group GmbH
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named AXPLORA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 12, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 30, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Dec 30, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Sep 3, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 3, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 3, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 15, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 15, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 9, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 17, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 7, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 7, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 7, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 23, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 29, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 29, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 13, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 7, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 10, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 10, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 10, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 10, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 2, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 2, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 2, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 25, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 6, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 2, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 2, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 20, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 19, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 9, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 6, 2023 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Jun 5, 2023 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Mar 14, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 10, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 9, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |